Literature DB >> 18076736

Permanent work disability in Crohn's disease.

Ashwin N Ananthakrishnan1, Lydia R Weber, Josh F Knox, Susan Skaros, Jeanne Emmons, Sarah Lundeen, Mazen Issa, Mary F Otterson, David G Binion.   

Abstract

OBJECTIVE: Crohn's disease (CD) frequently presents during early adulthood, a peak time of work productivity. There are limited data from the United States on work disability from CD. We performed this study to identify clinical factors associated with permanent work disability in a CD tertiary referral cohort.
METHODS: Cases were identified as patients who received permanent work disability compensation from the social security administration (SSA) related to CD. Four control patients who were not receiving work disability were selected for each case. Multivariate logistic regression was performed to identify characteristics that were independently associated with work disability.
RESULTS: A total of 737 patients with CD were seen in our center, and 185 CD patients were included in our study (37 disability cases, 148 controls). On multivariate analysis, an SIBDQ score <or=50 (OR 12.44, 95% CI 4.45-34.79), undergoing two or more GI surgeries (OR 7.09, 95% CI 2.63-19.11), and two or more medical hospitalizations (OR 2.76, 95% CI 1.03-7.37) were significantly associated with work disability in CD. Disease location (small bowel vs colon), type (inflammatory, stricturing, or fistulizing), or specific treatment strategies were not associated with work disability in our analysis.
CONCLUSION: Permanent work disability administered through social security was encountered in 5.3% of the Crohn's patients followed in our cohort. Patients who consistently report low quality of life, or have frequent flares requiring surgical intervention or hospitalization for medical management, may be at risk for CD-related work disability.

Entities:  

Mesh:

Year:  2007        PMID: 18076736     DOI: 10.1111/j.1572-0241.2007.01561.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  26 in total

1.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.

Authors:  Miguel Regueiro; Benjamin Click; Alyce Anderson; William Shrank; Jane Kogan; Sandra McAnallen; Eva Szigethy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-12       Impact factor: 11.382

3.  Optimizing management of Crohn's disease within a project management framework: results of a pilot study.

Authors:  Laurie Keefer; Bethany Doerfler; Caroline Artz
Journal:  Inflamm Bowel Dis       Date:  2011-02-23       Impact factor: 5.325

4.  Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.

Authors:  Remo Panaccione; Edward V Loftus; David Binion; Kevin McHugh; Shamsul Alam; Naijun Chen; Benoît Guerette; Parvez Mulani; Jingdong Chao
Journal:  Can J Gastroenterol       Date:  2011-08       Impact factor: 3.522

5.  The socio-economic impact of work disability due to inflammatory bowel disease in Brazil.

Authors:  Renata de S B Fróes; Ana Teresa Pugas Carvalho; Antonio Jose de V Carneiro; Adriana Maria Hilu de Barros Moreira; Jessica P L Moreira; Ronir R Luiz; Heitor S de Souza
Journal:  Eur J Health Econ       Date:  2017-05-18

6.  Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.

Authors:  Akbar K Waljee; Rachel Lipson; Wyndy L Wiitala; Yiwei Zhang; Boang Liu; Ji Zhu; Beth Wallace; Shail M Govani; Ryan W Stidham; Rodney Hayward; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

7.  Different faces of gastroparesis.

Authors:  Klaus Bielefeldt; Naeem Raza; Susan L Zickmund
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

8.  Behavioral interventions may prolong remission in patients with inflammatory bowel disease.

Authors:  Laurie Keefer; Jennifer L Kiebles; Zoran Martinovich; Elyse Cohen; Alyssa Van Denburg; Terrence A Barrett
Journal:  Behav Res Ther       Date:  2010-12-30

9.  Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.

Authors:  Benjamin Click; Claudia Ramos Rivers; Ioannis E Koutroubakis; Dmitriy Babichenko; Alyce M Anderson; Jana G Hashash; Michael A Dunn; Marc Schwartz; Jason Swoger; Leonard Baidoo; Arthur Barrie; Miguel Regueiro; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2016-06       Impact factor: 5.325

10.  Inflammatory bowel disease: a patient's and caregiver's perspective.

Authors:  F Magro; F Portela; P Lago; J Deus; J Cotter; I Cremers; A Vieira; P Peixe; P Caldeira; H Lopes; R Gonçalves; J Reis; M Cravo; L Barros; P Ministro; M Lurdes Tavares; A Duarte; M Campos; L Carvalho
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.